Related news from
Mon, 15 Apr 2024 13:40:11 +0000	Is Artivion (AORT) Outperforming Other Medical Stocks This Year? Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.
Mon, 15 Apr 2024 13:40:11 +0000	Here's Why Cencora (COR) is a Strong Value Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Fri, 05 Apr 2024 12:30:00 +0000	Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release CONSHOHOCKEN, Pa., April 05, 2024--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2024 on Wednesday, May 1, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 1, 2024.
Thu, 28 Mar 2024 13:40:12 +0000	Are Medical Stocks Lagging Artivion (AORT) This Year? Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.
Wed, 27 Mar 2024 13:45:11 +0000	Why Cencora (COR) is a Top Growth Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tue, 12 Mar 2024 12:30:00 +0000	Cencora Announces Leadership Succession Plan CONSHOHOCKEN, Pa., March 12, 2024--Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President and Chief Executive Officer of the Company and transition to the role of Executive Chair of the Cencora Board of Directors, effective October 1, 2024. Robert P. Mauch, PharmD, PhD, current Chief Operating Officer of Cencora, will succeed Collis as President and CEO, and will also be appointed as a member of the Company's Board, effective the same date.
Fri, 23 Feb 2024 14:45:11 +0000	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Thu, 08 Feb 2024 00:33:19 +0000	Walgreens Boots pockets $992 million after cutting Cencora stake for third time The proceeds include around $942 million from shares sold as well as about $50 million from a concurrent share repurchase by Cencora, formerly AmerisourceBergen. Walgreens has been grappling with waning demand for COVID-19 vaccines and testing as well as decreased spending on personal care and beauty products by inflation-weary consumers. It said it now owns around 13% of Cencora's common stock from 15% previously, and that it would use the sale proceeds primarily to pay down debt.
Wed, 07 Feb 2024 23:26:00 +0000	Cencora Announces Common Share Repurchase From Walgreens Boots Alliance CONSHOHOCKEN, Pa., February 07, 2024--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended.
Wed, 07 Feb 2024 23:16:00 +0000	Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds DEERFIELD, Ill., February 07, 2024--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold shares of Cencora, Inc. (NYSE: COR) common stock pursuant to Rule 144 for proceeds of approximately $942 million and, subject to the completion of the Rule 144 sale, a concurrent share repurchase by Cencora in the amount of approximately $50 million.
Wed, 07 Feb 2024 18:11:00 +0000	Cencora Closes $500 Million Senior Notes Offering CONSHOHOCKEN, Pa., February 07, 2024--Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500 million aggregate principal amount of its 5.125% Senior Notes due 2034 (the "Notes"), in an underwritten registered public offering. The offering was made pursuant to an effective shelf registration statement Cencora filed with the Securities and Exchange Commission (the "SEC") on November 23, 2021.
Mon, 05 Feb 2024 23:18:00 +0000	Cencora Prices $500 Million 5.125% Senior Notes Due 2034 CONSHOHOCKEN, Pa., February 05, 2024--Cencora, Inc. (NYSE: COR) today announced that it priced $500 million aggregate principal amount of its 5.125% Senior Notes due 2034 (the "Notes"), in an underwritten registered public offering. The offering is being made pursuant to an effective shelf registration statement Cencora filed with the Securities and Exchange Commission (the "SEC") on November 23, 2021. The offering is expected to close on February 7, 2024, subject to the satisfaction of customar
Sun, 04 Feb 2024 12:50:07 +0000	Companies test out different ways to talk about ESG without saying 'ESG' Mentions of ESG are falling again during this earnings season as bosses come up with different ways of talking about social responsibility and climate change.
Wed, 31 Jan 2024 11:30:00 +0000	Cencora Reports Fiscal 2024 First Quarter Results CONSHOHOCKEN, Pa., January 31, 2024--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 first quarter ended December 31, 2023, revenue increased 15.0 percent year-over-year to $72.3 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.98 for the first quarter of fiscal 2024 compared to $2.33 in the prior year first quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described
Tue, 30 Jan 2024 17:10:10 +0000	Why Cencora (COR) Could Beat Earnings Estimates Again Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Mon, 22 Jan 2024 14:15:06 +0000	Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Thu, 04 Jan 2024 21:30:00 +0000	Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release CONSHOHOCKEN, Pa., January 04, 2024--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2024 on Wednesday, January 31, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on January 31, 2024.
Tue, 05 Dec 2023 14:50:07 +0000	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wed, 22 Nov 2023 14:00:00 +0000	Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement Sapphiros, a platform company dedicated to building the next generation of consumer diagnostic technologies, is proud to announce it has entered into a distribution agreement with Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation.
Fri, 10 Nov 2023 01:16:59 +0000	Walgreens cuts Cencora stake further in $674 million share sale After the share repurchase, Walgreens now owns approximately 15% in drug distributor Cencora, it said, adding that it would use the proceeds to pay down debt. AmerisourceBergen disclosed plans early this year to rename itself as Cencora in a bid to expand internationally beyond drug distribution.

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!